Evidence map›Paper›PMID 36713002›Full record

ArticleEuropean heart journal. Digital health2022

Identification of undiagnosed atrial fibrillation using a machine learning risk-prediction algorithm and diagnostic testing (PULsE-AI) in primary care: a multi-centre randomized controlled trial in England.

Nathan R Hill, Lara Groves, Carissa Dickerson, Andreas Ochs, Dong Pang, Sarah Lawton, Michael Hurst, Kevin G Pollock, Daniel M Sugrue, Carmen Tsang and 11 more

Open access · goldAbstract read
In one paragraph

Article in European heart journal. Digital health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 3 pooled it
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 3 syntheses or guidelines pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Systematic, randomized atrial fibrillation screening using detailed phenotyping with a risk prediction model combined with patch electrocardiogram in a Swedish population aged 65 years or older: the CONSIDERING-AF trial.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2025
    Trial
  5. Trial
  6. Article
  7. [Atrial fibrillation screening-reading the P-wave].Innere Medizin (Heidelberg, Germany) · 2026
    Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 9 institutions in 2 countries.

Nathan R HillBristol Myers Squibb Pharmaceutical Ltd, Uxbridge, UK.ORCID https://orcid.org/0000-0001-7927-8678
Lara GrovesHealth Economics and Outcomes Research Ltd, Cardiff, UK.ORCID https://orcid.org/0000-0002-9577-1021
Carissa DickersonHealth Economics and Outcomes Research Ltd, Cardiff, UK.
Andreas OchsHealth Economics and Outcomes Research Ltd, Cardiff, UK.
Dong PangHealth Economics and Outcomes Research Ltd, Cardiff, UK.
Sarah LawtonSchool of Medicine, Keele University, Staffordshire, UK.
Michael HurstHealth Economics and Outcomes Research Ltd, Cardiff, UK.
Kevin G PollockBristol Myers Squibb Pharmaceutical Ltd, Uxbridge, UK.
Daniel M SugrueHealth Economics and Outcomes Research Ltd, Cardiff, UK.
Carmen TsangHealth Economics and Outcomes Research Ltd, Cardiff, UK.ORCID https://orcid.org/0000-0001-8210-5145
Chris ArdenUniversity Hospital Southampton, Southampton, UK.
David Wyn DaviesSt Mary's Hospital, London, UK.
Anne Celine MartinUniversité de Paris, INSERM, Innovative Therapies in Haemostasis, F-75006 Paris, France.
Belinda SandlerBristol Myers Squibb Pharmaceutical Ltd, Uxbridge, UK.
Jason GordonHealth Economics and Outcomes Research Ltd, Cardiff, UK.ORCID https://orcid.org/0000-0001-8635-742X
Usman FarooquiBristol Myers Squibb Pharmaceutical Ltd, Uxbridge, UK.
David CliftonInstitute of Biomedical Engineering, Department of Engineering Science, University of Oxford, Oxford, UK.
Christian MallenSchool of Medicine, Keele University, Staffordshire, UK.ORCID https://orcid.org/0000-0002-2677-1028
Jennifer RogersPHASTAR, London, UK.
Alan John CammCardiology Clinical Academic Group, Molecular & Clinical Sciences Research Institute, St George's University of London, London, UK.
Alexander T CohenDepartment of Haematological Medicine, Guys and St Thomas' NHS Foundation Trust, King's College London, London, UK.
Health Economics and Outcomes Research (United Kingdom) · GBBristol-Myers Squibb (United Kingdom) · GBKeele University · GBInserm · FRKing's College London · GBSt George's, University of London · GBSt Mary's Hospital · GBUniversity Hospital Southampton NHS Foundation Trust · GBUniversity of Oxford · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aims: The aim of the PULsE-AI trial was to assess the effectiveness of a machine learning risk-prediction algorithm in conjunction with diagnostic testing for identifying undiagnosed atrial fibrillation (AF) in primary care in England. Methods and results: Eligible participants (aged ≥30 years without AF diagnosis; Conclusion: The AF risk-prediction algorithm accurately identified high-risk participants in both arms. While the proportions of AF and related arrhythmia diagnoses were not significantly different between high-risk arms, intervention arm participants who underwent diagnostic testing were twice as likely to receive arrhythmia diagnoses compared with routine care. The algorithm could be a valuable tool to select primary care groups at high risk of undiagnosed AF who may benefit from diagnostic testing.

Indexed as

Atrial fibrillationMachine learningPrimary careRisk predictionScreening

Identifiers

PMID36713002
PMCPMC9707963
OpenAlexW4220750799

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.